Department of Internal Medicine.
Division of Gastroenterology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA.
J Clin Gastroenterol. 2022 Jan 1;56(1):e20-e26. doi: 10.1097/MCG.0000000000001458.
The goal of this study was to evaluate the inpatient mortality risk among geriatric patients with inflammatory bowel disease (IBD).
The challenges of caring for elderly patients with IBD will increase with the aging of the US population. Given the complications of hospitalization, we set to examine if elderly patients age older than 65 were at higher risk of mortality.
All patients with ulcerative colitis (UC) or Crohn's disease (CD) in the National Inpatient Sample (NIS) from 2016 and 2017 as the primary diagnosis or secondary diagnosis with an IBD-related cause of admission were included. Outcomes for patients aged above 65 were compared with below 65 using multivariable survey-adjusted regression. CD and UC were analyzed separately.
In 2016-2017, there were an estimated 162,800 admissions for CD and related complications compared with 96,450 for UC. In total, 30% of UC and 20% of CD admissions were geriatric. Geriatric status was associated with higher odds of mortality for CD [odds ratio (OR)=3.47, 95% confidence interval (CI): 2.72-4.44] and UC (OR=2.75, 95% CI: 2.16-3.49) after adjustment for comorbidities, admission type, hospital type, inpatient surgery, and IBD subtype. The cause of death was ∼80% infectious in both CD and UC in all groups. An average of 0.19 days (95% CI: 0.05-0.34) and $2467 (95% CI: 545-4388) increase was seen for geriatric CD patients. No significant change was seen for UC.
Age over 65 was independently associated with higher odds of death in both UC and CD patients, even after appropriate adjustment. Further research is needed to optimize care for this growing patient population.
本研究旨在评估炎症性肠病(IBD)老年患者的住院死亡率风险。
随着美国人口老龄化,照顾老年 IBD 患者的挑战将会增加。鉴于住院治疗的复杂性,我们研究了年龄超过 65 岁的老年患者是否有更高的死亡风险。
本研究纳入了 2016 年至 2017 年国家住院患者样本(NIS)中溃疡性结肠炎(UC)或克罗恩病(CD)的所有患者,他们的主要诊断或次要诊断为 IBD 相关入院原因。使用多变量调查调整回归比较了 65 岁以上和 65 岁以下患者的结局。分别对 CD 和 UC 进行了分析。
在 2016-2017 年,估计有 162800 例 CD 及相关并发症入院,而 UC 则为 96450 例。在 UC 和 CD 中,30%的住院患者和 20%的入院患者为老年患者。调整合并症、入院类型、医院类型、住院手术和 IBD 亚型后,老年患者的 CD(优势比[OR]=3.47,95%置信区间[CI]:2.72-4.44)和 UC(OR=2.75,95% CI:2.16-3.49)的死亡风险更高。在所有患者中,CD 和 UC 的死亡原因约 80%为感染。老年 CD 患者的平均死亡时间延长 0.19 天(95% CI:0.05-0.34),住院费用增加 2467 美元(95% CI:545-4388)。UC 患者则没有显著变化。
即使经过适当调整,年龄超过 65 岁与 UC 和 CD 患者的死亡风险增加独立相关。需要进一步研究以优化对这一不断增长的患者群体的治疗。